Medical Devices Startups

ShopJourney sells the Journey Air Elite Max, an ultra-lightweight carbon fiber power chair designed for individuals with mobility challenges. The chair features dual lithium batteries for extended range, FAA compliance for air travel, and a 330 lb weight capacity.

1 investor

Shuwen Biotech develops molecular and immunodiagnostic products for women's health, including breast cancer subtyping kits, nucleic acid extraction systems, and point-of-care tests for pregnancy complications. The company serves healthcare providers and pharmaceutical clients in clinical diagnostics and personalized medicine.

1 investor

Sibel Health develops wireless vital signs monitoring sensors and data integration technology for healthcare providers, used across neonatal, maternal, adult, remote patient monitoring, and hospital-at-home care. The company deploys its medical monitoring devices in more than 20 countries for global health applications.

1 investor

A medical technology company developing innovative healthcare products including glucose monitoring and AI-powered retinal screening solutions, serving consumers and healthcare professionals.

1 investor

SiDLY builds medical wearable wristbands with SOS, GPS and vital-sign sensors, paired with a mobile app and web platform for real-time patient monitoring, caregiver coordination and emergency response. Its AI-supported system serves patients, caregivers and medical tele-centers, and the products are designed and manufactured in Poland.

1 investor

Sierra Labs provides software to automate compliance and quality management processes for life science teams, aiming to reduce the cost and effort of meeting regulatory standards. It focuses on integrating quality management with technology and building compliance programs in regulated environments.

1 investor

SignaCor is a clinical-stage biotech company developing Cardiaza, a first-in-class injectable epigenetic (DNA methylation inhibiting) therapy for symptomatic hypertrophic cardiomyopathy that targets underlying disease mechanisms such as cardiac fibrosis rather than only symptoms. Spun out of Queen's University Belfast, the company focuses on therapeutics for cardiac disease.

1 investor

Signature Diagnostics develops noninvasive diagnostic and screening tools, including noninvasive prenatal screening (NIPS) and pharmacogenomic (PGx) testing, based on genomics research into women's reproductive and organ health. It operates SDxLabs, a CLIA-certified clinical lab offering these testing services.

1 investor

Silicodata is a pharmaceutical company composed of professionals with over 25 years of industry experience, focused on rethinking how medicine is manufactured.

1 investor

Siloam Vision develops medical imaging and software solutions for eye care, with initial focus on retinopathy of prematurity (ROP) in premature infants. The company offers hardware (scanning laser ophthalmoscope and OCT systems) and AI-assisted software platforms for ophthalmologists and eye care providers worldwide.

1 investor

Siloton develops photonic chip technology that miniaturizes the optical hardware behind OCT (optical coherence tomography) eye scanning onto a coin-sized chip, enabling a portable eye scanner for use in clinics, community settings, and at home. It also offers OCT-Chip Development Kits for other market segments, targeting ophthalmic diagnostics and medical imaging.

1 investor

Silverspurt develops a peptide amphiphile micelle platform for precise, tissue-targeted delivery of small-molecule drugs and genetic therapeutics, reducing systemic toxicity and off-target effects. The platform is designed to improve therapeutic efficacy and patient compliance across multiple therapeutic modalities.

1 investor

Sim&Cure develops software for brain aneurysm and neurovascular treatment, using digital twin and AI technologies to support physicians during endovascular procedures. Its tools are aimed at healthcare professionals and hospitals to improve procedural outcomes and patient care.

1 investor

Simbryo Technologies is a biotech company that creates endometrial organoids from a patient's own stem cells using a routine biopsy, offering functional diagnostic tests of the uterine lining to assess and optimize endometrial fertility. Working with research institutions and fertility clinics, it uses organoid medicine and AI to give patients and physicians insights aimed at improving IVF success rates and to serve as a test bed for new fertility treatments.

1 investor

SimedX operates an AI-powered intensive care platform that uses clinical data to provide decision support for acute respiratory care in critical care settings.

1 investor

Simple Strips makes affordable blood glucose test strips that users can photograph and read using their smartphone camera, providing an accessible alternative to traditional glucose meters.

1 investor

SIMPLEX QUANTUM develops AI-powered software libraries that analyze electrocardiogram (ECG) signals to detect cardiac abnormalities, monitor stress levels, and perform biometric authentication for healthcare and wellness applications. The company serves healthcare providers, diagnostic centers, and organizations seeking non-invasive cardiac monitoring and stress assessment solutions.

1 investor

Singletto develops Oxafence Active Protection™, a materials-applied antimicrobial technology integrated into protective materials such as masks, using photodynamic approaches to enable active microbial inactivation during use. The company licenses its platform technology to healthcare, operational, and emerging markets where traditional antimicrobial solutions have proven limited.

1 investor

Singular Photonics develops digital image sensors based on single-photon avalanche diode (SPAD) technology, which convert photons directly into digital signals to capture depth and temporal data as 4D images. The sensors are designed for time-resolved imaging at very low light levels without analogue signal processing.

1 investor

SiNON Nano Sciences develops carbon nanoparticles for therapeutic and diagnostic applications, including targeted drug delivery, fluorescent bio-imaging, and treatments for oncology, diabetes, and cardiology.

1 investor

Sinotau develops radiopharmaceutical products, including diagnostic imaging agents for early detection of Alzheimer's disease. The company operates in the radiopharmaceutical sector in China, serving medical institutions and hospitals.

1 investor

Sinovision Tech develops high-end medical imaging equipment specializing in CT (computed tomography) systems, complemented by cloud-based service platforms and remote diagnostic technologies. The company serves global healthcare institutions with integrated diagnostic imaging solutions.

1 investor

SinuSauna is a wearable mask device that delivers heated dry air therapy to the nasal passages for congestion relief and germ reduction. It serves consumers seeking natural sinus and cold symptom management.

1 investor

Sira Medical develops augmented reality technology for preoperative surgical planning that helps doctors visualize medical imaging in a spatial context. The company serves surgeons and radiologists seeking to improve the safety and efficiency of surgical procedures.

1 investor